ArticleHaematologica2025

A phase II trial of azacitidine with ipilimumab, nivolumab, or ipilimumab and nivolumab in previously untreated myelodysplastic syndrome.

Ian M Bouligny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.